Tag Archives: IOVA

Oppenheimer Remains a Buy on Iovance Biotherapeutics Inc (IOVA)

In a report released today, Mark Breidenbach from Oppenheimer maintained a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $25. The company’s shares closed yesterday at $9.38. Breidenbach noted: “Wednesday, we sat down

A Director at Iovance Biotherapeutics Inc (NASDAQ: IOVA) is Buying Shares

Today, a Director at Iovance Biotherapeutics Inc (IOVA – Research Report), Merrill A Mcpeak, bought shares of IOVA for $96.2K. This is Mcpeak’s first transaction since reporting a Buy transaction on LLEX back in May 2015 This recent transaction increases

H.C. Wainwright Thinks Iovance Biotherapeutics Inc’s Stock is Going to Recover

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $26. The company’s shares closed on Friday at $8.97, close to its 52-week

B.Riley FBR Thinks Iovance Biotherapeutics Inc’s Stock is Going to Recover

In a report released today, Madhu Kumar from B.Riley FBR reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $24. The company’s shares closed yesterday at $8.80, close to its 52-week low

Iovance Biotherapeutics Inc (IOVA) Gets a Buy Rating from Cowen & Co.

In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report). The company’s shares opened today at $8.80, close to its 52-week low of $7.13. According to TipRanks.com,

H.C. Wainwright Sticks to Their Buy Rating for Iovance Biotherapeutics Inc (IOVA)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA) today and set a price target of $26. The company’s shares opened today at $11.23. Pantginis wrote: “Valuation and impediments to achieving price target. We